Researchers shed light on risks presented by residual disease for younger breast canc

[News]

A new study from the Stanford Cancer Institute finds that young women who are treated with chemotherapy for breast cancer but have residual tumor in either the breast or lymph nodes have higher chances of recurrence compared to those with no evidence of any residual invasive tumor (pathologic complete response).

More... (https://www.news-medical.net/news/20180723/Researchers-shed-light-on-risks-presented-by-residual-disease-for-younger-breast-cancer-patients.aspx)